Clorox Co
Consumer products
Clorox Co (CLX) Stock News
The latest CLX headlines and market coverage — 4 recent stories, updated throughout the day.
- Zacks Investment Research·Neutral
Is AB Discovery Growth A (CHCLX) a Strong Mutual Fund Pick Right Now?
AB Discovery Growth A (CHCLX), a mid-cap growth mutual fund managed by AllianceBernstein, has received a Zacks Mutual Fund Rank of 1 (Strong Buy). However, the fund shows mixed performance metrics: weak 5-year returns (0.38%), higher volatility than peers, and negative alpha (-11.93%), indicating difficulty in outperforming benchmarks. Despite these concerns, its lower expense ratio (0.91%) and strong Zacks ranking suggest it may be worth considering for investors.
- Zacks Investment Research·
ADRNY vs. CLX: Which Stock Should Value Investors Buy Now?
A comparison of two consumer staples stocks reveals that Ahold NV (ADRNY) presents a better value opportunity than Clorox (CLX). ADRNY has a superior Zacks Rank of #2 (Buy) versus CLX's #3 (Hold), along with more attractive valuation metrics including a lower forward P/E ratio (11.70 vs 14.87) and significantly lower P/B ratio (1.93 vs 40.72). ADRNY earned a Value grade of A compared to CLX's C grade.
- Zacks Investment Research·Neutral
ADRNY or CLX: Which Is the Better Value Stock Right Now?
A comparison of two consumer staples stocks reveals that Ahold NV (ADRNY) presents a better value opportunity than Clorox (CLX) for value investors. ADRNY has a stronger Zacks Rank of #2 (Buy) versus CLX's #4 (Sell), along with more attractive valuation metrics including a lower forward P/E ratio (11.26 vs 16.67) and significantly lower P/B ratio (1.8 vs 46.88).
- Benzinga·
Scilex (SCLX) Stock Jumps After Dream Bowl Meme Coin Listing Update: Why Is It Moving?
Scilex Holding Company shares surged 18.79% after announcing that its Dream Bowl I Meme Coin tokens will begin trading on Biconomy Exchange as early as June 23. The listing is expected to improve liquidity and enable broader distribution for eligible token holders. Scilex is a biotech company focused on non-opioid pain management products.